Cornelia Feiterna‐Sperling

Author

Charité - Universitätsmedizin Berlin ORCID

Also Known As

Antonio Del Valle-Segarra, C Feiterna-Sperling, C Feiterna‐Sperling, C. FEITERNA-SPERLING, C. Feiterna-Sperling, C. Feiterna‐Sperling, CORNELIA FEITERNA-SPERLING, Claire-Michele Farber, Cornelia Feiterna-Sperling, Cornelia Feiterna‐Sperling

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin Goethe University Frankfurt University Hospital Frankfurt Humboldt-Universität zu Berlin Boston Children's Hospital

About

Cornelia Feiterna‐Sperling is an author at Charité - Universitätsmedizin Berlin specializing in medicine, pediatrics, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	236
2	Public Health	2	2	33
3	Education	1	1	24
4	Allergy	1	1	24
5	Epidemiology	1	1	20

Cornelia Feiterna‐Sperling

Publications

793

Citations

H-Index

Page 1

	Year	Citations
Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV‐1‐infected women I Grosch‐Woerner, K Puch, RF Maier, HIV Medicine	2008	131
Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA Study Maureen M. Jonas, Robert H. Squires, Susan Rhee, Hepatology Part 1HepatologyHepatitis CAdolescent PatientsViral Hepatitis	2019	106
Hematologic Effects of Maternal Antiretroviral Therapy and Transmission Prophylaxis in HIV-1-Exposed Uninfected Newborn Infants Cornelia Feiterna‐Sperling, Katharina Weizsaecker, Christoph Bührer, JAIDS Journal of Acquired Immune Deficiency Syndromes	2007	82
Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children G Kanra, Paola Marchisio, Cornelia Feiterna‐Sperling, The Pediatric Infectious Disease Journal	2004	72
Sofosbuvir and Ribavirin Therapy for Children Aged 3 to <12 Years With Hepatitis C Virus Genotype 2 or 3 Infection Philip Rosenthal, Kathleen B. Schwarz, Regino P. González‐Peralta, Hepatology Accidental RibavirinPharmacotherapyAntiviral DrugViral HepatitisClinical Epidemiology	2019	60
Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Children With Chronic HCV: Part 2 of the DORA Study Maureen M. Jonas, Susan Rhee, Déirdre Kelly, Hepatology	2021	56
An effective and safe protocol involving zidovudine and caesarean section to reduce vertical transmission of HIV-1 infection llse Grosch-Wörner, Axel Schäfer, Michael Obladen, AIDS	2000	41
Performance of QuantiFERON-TB Gold Plus assays in paediatric tuberculosis: a multicentre PTBNET study Danilo Buonsenso, Antoni Noguera‐Julián, Rossana Moroni, Thorax	2022	35
Not Recommended, But Done: Breastfeeding with HIV in Germany Lila Haberl, Franz Audebert, Cornelia Feiterna‐Sperling, AIDS Patient Care and STDs	2021	26
Granulysin-Expressing CD4+ T Cells as Candidate Immune Marker for Tuberculosis during Childhood and Adolescence H. Mueller, Kellen C. Faé, K. Magdorf, PLoS ONE	2011	24

Page 1